We would like to thank Dr Sunil Verma for providing us with the latest oncology updates

 

Lapatinib (L) plus Capecitabine (C) in her2+ advanced breast cancer (ABC): report of updated efficacy and gene array data

Multiple lines of trastuzumab provide a survival benefit for women with metastatic breast cancer: results from the Hermine cohort study

 

---

Article Review

Article Review: Her2 and Response to Paclitaxel in Node Positive Breast Cancer
Original Authors: DF Hayes et al
Citation: NEJM. Oct 11 2007; 357(15):1496-506
Article: Journal | Pubmed | ASCO Perspectives